Neurotech platform bridging in-vivo brain data with in-silico computational models for neuroscience and medical applications.
Piramidal is a neurotech startup developing technology to bridge in-vivo and in-silico neuroscience, focused on understanding and controlling neural syntax. The company raised a $6M seed round led by Y Combinator with advisors from King's College London, Cleveland Clinic, and Stanford. The specific product offering is not detailed on the public website. Piramidal is a product of Piramidal.